nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—ALB—stomach cancer	0.264	1	CbGaD
Valsartan—SLCO1B3—Docetaxel—stomach cancer	0.107	0.216	CbGbCtD
Valsartan—SLCO1B1—Irinotecan—stomach cancer	0.0853	0.172	CbGbCtD
Valsartan—SLCO1B3—Methotrexate—stomach cancer	0.0775	0.156	CbGbCtD
Valsartan—ALB—Irinotecan—stomach cancer	0.0467	0.0941	CbGbCtD
Valsartan—SLCO1B1—Methotrexate—stomach cancer	0.0451	0.0909	CbGbCtD
Valsartan—ALB—Fluorouracil—stomach cancer	0.0448	0.0903	CbGbCtD
Valsartan—CYP2C9—Capecitabine—stomach cancer	0.0408	0.0821	CbGbCtD
Valsartan—ALB—Methotrexate—stomach cancer	0.0247	0.0498	CbGbCtD
Valsartan—CYP2C9—Fluorouracil—stomach cancer	0.0242	0.0487	CbGbCtD
Valsartan—Tasosartan—AGTR2—stomach cancer	0.00453	0.673	CrCbGaD
Valsartan—AGTR1—blood vessel—stomach cancer	0.00287	0.127	CbGeAlD
Valsartan—ALB—gall bladder—stomach cancer	0.00208	0.0925	CbGeAlD
Valsartan—Irbesartan—JUN—stomach cancer	0.00166	0.247	CrCbGaD
Valsartan—AGTR1—hematopoietic system—stomach cancer	0.00153	0.0679	CbGeAlD
Valsartan—SLCO1B1—hematopoietic system—stomach cancer	0.00146	0.0647	CbGeAlD
Valsartan—SLCO1B3—endocrine gland—stomach cancer	0.00145	0.0643	CbGeAlD
Valsartan—AGTR1—epithelium—stomach cancer	0.0014	0.062	CbGeAlD
Valsartan—AGTR1—smooth muscle tissue—stomach cancer	0.00135	0.0598	CbGeAlD
Valsartan—SLCO1B3—liver—stomach cancer	0.00131	0.058	CbGeAlD
Valsartan—AGTR1—lymphoid tissue—stomach cancer	0.00108	0.0478	CbGeAlD
Valsartan—SLCO1B1—digestive system—stomach cancer	0.00101	0.045	CbGeAlD
Valsartan—AGTR1—endocrine gland—stomach cancer	0.000878	0.039	CbGeAlD
Valsartan—SLCO1B1—endocrine gland—stomach cancer	0.000837	0.0372	CbGeAlD
Valsartan—AGTR1—liver—stomach cancer	0.000792	0.0352	CbGeAlD
Valsartan—SLCO1B1—liver—stomach cancer	0.000755	0.0335	CbGeAlD
Valsartan—CYP2C9—hematopoietic system—stomach cancer	0.000736	0.0327	CbGeAlD
Valsartan—ALB—liver—stomach cancer	0.000611	0.0271	CbGeAlD
Valsartan—AGTR1—lymph node—stomach cancer	0.000607	0.027	CbGeAlD
Valsartan—CYP2C9—digestive system—stomach cancer	0.000512	0.0227	CbGeAlD
Valsartan—ALB—lymph node—stomach cancer	0.000468	0.0208	CbGeAlD
Valsartan—CYP2C9—endocrine gland—stomach cancer	0.000423	0.0188	CbGeAlD
Valsartan—Losartan—ACE—stomach cancer	0.000384	0.057	CrCbGaD
Valsartan—CYP2C9—liver—stomach cancer	0.000381	0.0169	CbGeAlD
Valsartan—Diarrhoea—Irinotecan—stomach cancer	0.000183	0.00113	CcSEcCtD
Valsartan—Dry mouth—Capecitabine—stomach cancer	0.000182	0.00113	CcSEcCtD
Valsartan—Shock—Docetaxel—stomach cancer	0.000181	0.00113	CcSEcCtD
Valsartan—Nervous system disorder—Docetaxel—stomach cancer	0.000181	0.00112	CcSEcCtD
Valsartan—Pruritus—Fluorouracil—stomach cancer	0.000181	0.00112	CcSEcCtD
Valsartan—Thrombocytopenia—Docetaxel—stomach cancer	0.000181	0.00112	CcSEcCtD
Valsartan—Infestation NOS—Doxorubicin—stomach cancer	0.00018	0.00112	CcSEcCtD
Valsartan—Infestation—Doxorubicin—stomach cancer	0.00018	0.00112	CcSEcCtD
Valsartan—Skin disorder—Docetaxel—stomach cancer	0.000179	0.00111	CcSEcCtD
Valsartan—Oedema—Capecitabine—stomach cancer	0.000179	0.00111	CcSEcCtD
Valsartan—Renal failure—Doxorubicin—stomach cancer	0.000177	0.0011	CcSEcCtD
Valsartan—Infection—Capecitabine—stomach cancer	0.000177	0.0011	CcSEcCtD
Valsartan—Dizziness—Irinotecan—stomach cancer	0.000176	0.00109	CcSEcCtD
Valsartan—Haemoglobin—Epirubicin—stomach cancer	0.000176	0.00109	CcSEcCtD
Valsartan—Anorexia—Docetaxel—stomach cancer	0.000176	0.00109	CcSEcCtD
Valsartan—Shock—Capecitabine—stomach cancer	0.000176	0.00109	CcSEcCtD
Valsartan—Rhinitis—Epirubicin—stomach cancer	0.000176	0.00109	CcSEcCtD
Valsartan—Nervous system disorder—Capecitabine—stomach cancer	0.000175	0.00109	CcSEcCtD
Valsartan—Haemorrhage—Epirubicin—stomach cancer	0.000175	0.00109	CcSEcCtD
Valsartan—Hepatitis—Epirubicin—stomach cancer	0.000175	0.00109	CcSEcCtD
Valsartan—Diarrhoea—Fluorouracil—stomach cancer	0.000175	0.00109	CcSEcCtD
Valsartan—Thrombocytopenia—Capecitabine—stomach cancer	0.000175	0.00109	CcSEcCtD
Valsartan—Pharyngitis—Epirubicin—stomach cancer	0.000174	0.00108	CcSEcCtD
Valsartan—Cardiac disorder—Methotrexate—stomach cancer	0.000174	0.00108	CcSEcCtD
Valsartan—Skin disorder—Capecitabine—stomach cancer	0.000173	0.00108	CcSEcCtD
Valsartan—Urinary tract disorder—Epirubicin—stomach cancer	0.000173	0.00107	CcSEcCtD
Valsartan—Hypotension—Docetaxel—stomach cancer	0.000172	0.00107	CcSEcCtD
Valsartan—Connective tissue disorder—Epirubicin—stomach cancer	0.000172	0.00107	CcSEcCtD
Valsartan—Urethral disorder—Epirubicin—stomach cancer	0.000172	0.00107	CcSEcCtD
Valsartan—Epistaxis—Doxorubicin—stomach cancer	0.00017	0.00106	CcSEcCtD
Valsartan—Anorexia—Capecitabine—stomach cancer	0.00017	0.00106	CcSEcCtD
Valsartan—Angiopathy—Methotrexate—stomach cancer	0.00017	0.00105	CcSEcCtD
Valsartan—Vomiting—Irinotecan—stomach cancer	0.00017	0.00105	CcSEcCtD
Valsartan—Sinusitis—Doxorubicin—stomach cancer	0.000169	0.00105	CcSEcCtD
Valsartan—Immune system disorder—Methotrexate—stomach cancer	0.000169	0.00105	CcSEcCtD
Valsartan—Dizziness—Fluorouracil—stomach cancer	0.000169	0.00105	CcSEcCtD
Valsartan—Mediastinal disorder—Methotrexate—stomach cancer	0.000169	0.00105	CcSEcCtD
Valsartan—Rash—Irinotecan—stomach cancer	0.000168	0.00104	CcSEcCtD
Valsartan—Dermatitis—Irinotecan—stomach cancer	0.000168	0.00104	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000168	0.00104	CcSEcCtD
Valsartan—Headache—Irinotecan—stomach cancer	0.000167	0.00104	CcSEcCtD
Valsartan—Hypotension—Capecitabine—stomach cancer	0.000167	0.00104	CcSEcCtD
Valsartan—Insomnia—Docetaxel—stomach cancer	0.000167	0.00104	CcSEcCtD
Valsartan—Paraesthesia—Docetaxel—stomach cancer	0.000166	0.00103	CcSEcCtD
Valsartan—Alopecia—Methotrexate—stomach cancer	0.000165	0.00103	CcSEcCtD
Valsartan—Dyspnoea—Docetaxel—stomach cancer	0.000164	0.00102	CcSEcCtD
Valsartan—Somnolence—Docetaxel—stomach cancer	0.000164	0.00102	CcSEcCtD
Valsartan—Mental disorder—Methotrexate—stomach cancer	0.000164	0.00102	CcSEcCtD
Valsartan—Malnutrition—Methotrexate—stomach cancer	0.000163	0.00101	CcSEcCtD
Valsartan—Haemoglobin—Doxorubicin—stomach cancer	0.000163	0.00101	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000163	0.00101	CcSEcCtD
Valsartan—Cardiac disorder—Epirubicin—stomach cancer	0.000162	0.00101	CcSEcCtD
Valsartan—Vomiting—Fluorouracil—stomach cancer	0.000162	0.00101	CcSEcCtD
Valsartan—Rhinitis—Doxorubicin—stomach cancer	0.000162	0.00101	CcSEcCtD
Valsartan—Dyspepsia—Docetaxel—stomach cancer	0.000162	0.00101	CcSEcCtD
Valsartan—Haemorrhage—Doxorubicin—stomach cancer	0.000162	0.00101	CcSEcCtD
Valsartan—Hepatitis—Doxorubicin—stomach cancer	0.000162	0.00101	CcSEcCtD
Valsartan—Insomnia—Capecitabine—stomach cancer	0.000161	0.001	CcSEcCtD
Valsartan—Rash—Fluorouracil—stomach cancer	0.000161	0.001	CcSEcCtD
Valsartan—Dermatitis—Fluorouracil—stomach cancer	0.000161	0.000999	CcSEcCtD
Valsartan—Pharyngitis—Doxorubicin—stomach cancer	0.000161	0.000998	CcSEcCtD
Valsartan—Paraesthesia—Capecitabine—stomach cancer	0.00016	0.000995	CcSEcCtD
Valsartan—Decreased appetite—Docetaxel—stomach cancer	0.00016	0.000995	CcSEcCtD
Valsartan—Headache—Fluorouracil—stomach cancer	0.00016	0.000993	CcSEcCtD
Valsartan—Urinary tract disorder—Doxorubicin—stomach cancer	0.00016	0.000993	CcSEcCtD
Valsartan—Dysgeusia—Methotrexate—stomach cancer	0.000159	0.00099	CcSEcCtD
Valsartan—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000159	0.000988	CcSEcCtD
Valsartan—Connective tissue disorder—Doxorubicin—stomach cancer	0.000159	0.000988	CcSEcCtD
Valsartan—Dyspnoea—Capecitabine—stomach cancer	0.000159	0.000988	CcSEcCtD
Valsartan—Fatigue—Docetaxel—stomach cancer	0.000159	0.000987	CcSEcCtD
Valsartan—Angiopathy—Epirubicin—stomach cancer	0.000159	0.000986	CcSEcCtD
Valsartan—Urethral disorder—Doxorubicin—stomach cancer	0.000159	0.000986	CcSEcCtD
Valsartan—Nausea—Irinotecan—stomach cancer	0.000158	0.000984	CcSEcCtD
Valsartan—Immune system disorder—Epirubicin—stomach cancer	0.000158	0.000982	CcSEcCtD
Valsartan—Mediastinal disorder—Epirubicin—stomach cancer	0.000158	0.000979	CcSEcCtD
Valsartan—Constipation—Docetaxel—stomach cancer	0.000158	0.000979	CcSEcCtD
Valsartan—Back pain—Methotrexate—stomach cancer	0.000158	0.000978	CcSEcCtD
Valsartan—Losartan—ALB—stomach cancer	0.000158	0.0234	CrCbGaD
Valsartan—Dyspepsia—Capecitabine—stomach cancer	0.000157	0.000976	CcSEcCtD
Valsartan—Decreased appetite—Capecitabine—stomach cancer	0.000155	0.000963	CcSEcCtD
Valsartan—Alopecia—Epirubicin—stomach cancer	0.000155	0.00096	CcSEcCtD
Valsartan—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000154	0.000957	CcSEcCtD
Valsartan—Fatigue—Capecitabine—stomach cancer	0.000154	0.000955	CcSEcCtD
Valsartan—Vision blurred—Methotrexate—stomach cancer	0.000153	0.000953	CcSEcCtD
Valsartan—Mental disorder—Epirubicin—stomach cancer	0.000153	0.000952	CcSEcCtD
Valsartan—Constipation—Capecitabine—stomach cancer	0.000153	0.000948	CcSEcCtD
Valsartan—Malnutrition—Epirubicin—stomach cancer	0.000152	0.000946	CcSEcCtD
Valsartan—Nausea—Fluorouracil—stomach cancer	0.000152	0.000942	CcSEcCtD
Valsartan—Gastrointestinal pain—Docetaxel—stomach cancer	0.000151	0.000936	CcSEcCtD
Valsartan—Cardiac disorder—Doxorubicin—stomach cancer	0.00015	0.000933	CcSEcCtD
Valsartan—Flatulence—Epirubicin—stomach cancer	0.00015	0.000932	CcSEcCtD
Valsartan—Dysgeusia—Epirubicin—stomach cancer	0.000149	0.000926	CcSEcCtD
Valsartan—Back pain—Epirubicin—stomach cancer	0.000147	0.000915	CcSEcCtD
Valsartan—Angiopathy—Doxorubicin—stomach cancer	0.000147	0.000912	CcSEcCtD
Valsartan—Muscle spasms—Epirubicin—stomach cancer	0.000147	0.000909	CcSEcCtD
Valsartan—Immune system disorder—Doxorubicin—stomach cancer	0.000146	0.000908	CcSEcCtD
Valsartan—Vertigo—Methotrexate—stomach cancer	0.000146	0.000908	CcSEcCtD
Valsartan—Gastrointestinal pain—Capecitabine—stomach cancer	0.000146	0.000906	CcSEcCtD
Valsartan—Mediastinal disorder—Doxorubicin—stomach cancer	0.000146	0.000906	CcSEcCtD
Valsartan—Abdominal pain—Docetaxel—stomach cancer	0.000146	0.000905	CcSEcCtD
Valsartan—Vision blurred—Epirubicin—stomach cancer	0.000144	0.000892	CcSEcCtD
Valsartan—Alopecia—Doxorubicin—stomach cancer	0.000143	0.000889	CcSEcCtD
Valsartan—Cough—Methotrexate—stomach cancer	0.000142	0.000882	CcSEcCtD
Valsartan—Mental disorder—Doxorubicin—stomach cancer	0.000142	0.000881	CcSEcCtD
Valsartan—Urticaria—Capecitabine—stomach cancer	0.000142	0.00088	CcSEcCtD
Valsartan—Abdominal pain—Capecitabine—stomach cancer	0.000141	0.000876	CcSEcCtD
Valsartan—Malnutrition—Doxorubicin—stomach cancer	0.000141	0.000875	CcSEcCtD
Valsartan—Flatulence—Doxorubicin—stomach cancer	0.000139	0.000862	CcSEcCtD
Valsartan—Chest pain—Methotrexate—stomach cancer	0.000139	0.000861	CcSEcCtD
Valsartan—Arthralgia—Methotrexate—stomach cancer	0.000139	0.000861	CcSEcCtD
Valsartan—Myalgia—Methotrexate—stomach cancer	0.000139	0.000861	CcSEcCtD
Valsartan—Dysgeusia—Doxorubicin—stomach cancer	0.000138	0.000857	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000138	0.000855	CcSEcCtD
Valsartan—Vertigo—Epirubicin—stomach cancer	0.000137	0.00085	CcSEcCtD
Valsartan—Syncope—Epirubicin—stomach cancer	0.000137	0.000848	CcSEcCtD
Valsartan—Back pain—Doxorubicin—stomach cancer	0.000136	0.000847	CcSEcCtD
Valsartan—Hypersensitivity—Docetaxel—stomach cancer	0.000136	0.000843	CcSEcCtD
Valsartan—Muscle spasms—Doxorubicin—stomach cancer	0.000136	0.000842	CcSEcCtD
Valsartan—Palpitations—Epirubicin—stomach cancer	0.000135	0.000836	CcSEcCtD
Valsartan—Loss of consciousness—Epirubicin—stomach cancer	0.000134	0.000831	CcSEcCtD
Valsartan—Cough—Epirubicin—stomach cancer	0.000133	0.000825	CcSEcCtD
Valsartan—Anaphylactic shock—Methotrexate—stomach cancer	0.000133	0.000825	CcSEcCtD
Valsartan—Vision blurred—Doxorubicin—stomach cancer	0.000133	0.000825	CcSEcCtD
Valsartan—Asthenia—Docetaxel—stomach cancer	0.000132	0.000821	CcSEcCtD
Valsartan—Infection—Methotrexate—stomach cancer	0.000132	0.00082	CcSEcCtD
Valsartan—Hypersensitivity—Capecitabine—stomach cancer	0.000132	0.000816	CcSEcCtD
Valsartan—Pruritus—Docetaxel—stomach cancer	0.00013	0.00081	CcSEcCtD
Valsartan—Nervous system disorder—Methotrexate—stomach cancer	0.00013	0.000809	CcSEcCtD
Valsartan—Thrombocytopenia—Methotrexate—stomach cancer	0.00013	0.000808	CcSEcCtD
Valsartan—Myalgia—Epirubicin—stomach cancer	0.00013	0.000805	CcSEcCtD
Valsartan—Chest pain—Epirubicin—stomach cancer	0.00013	0.000805	CcSEcCtD
Valsartan—Arthralgia—Epirubicin—stomach cancer	0.00013	0.000805	CcSEcCtD
Valsartan—Anxiety—Epirubicin—stomach cancer	0.000129	0.000803	CcSEcCtD
Valsartan—Skin disorder—Methotrexate—stomach cancer	0.000129	0.000801	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000129	0.0008	CcSEcCtD
Valsartan—Asthenia—Capecitabine—stomach cancer	0.000128	0.000795	CcSEcCtD
Valsartan—Dry mouth—Epirubicin—stomach cancer	0.000127	0.000788	CcSEcCtD
Valsartan—Vertigo—Doxorubicin—stomach cancer	0.000127	0.000786	CcSEcCtD
Valsartan—Anorexia—Methotrexate—stomach cancer	0.000127	0.000786	CcSEcCtD
Valsartan—Syncope—Doxorubicin—stomach cancer	0.000126	0.000785	CcSEcCtD
Valsartan—Pruritus—Capecitabine—stomach cancer	0.000126	0.000784	CcSEcCtD
Valsartan—Diarrhoea—Docetaxel—stomach cancer	0.000126	0.000783	CcSEcCtD
Valsartan—Palpitations—Doxorubicin—stomach cancer	0.000125	0.000773	CcSEcCtD
Valsartan—Anaphylactic shock—Epirubicin—stomach cancer	0.000124	0.000772	CcSEcCtD
Valsartan—Oedema—Epirubicin—stomach cancer	0.000124	0.000772	CcSEcCtD
Valsartan—Hypotension—Methotrexate—stomach cancer	0.000124	0.000771	CcSEcCtD
Valsartan—Loss of consciousness—Doxorubicin—stomach cancer	0.000124	0.000769	CcSEcCtD
Valsartan—Infection—Epirubicin—stomach cancer	0.000124	0.000767	CcSEcCtD
Valsartan—Cough—Doxorubicin—stomach cancer	0.000123	0.000764	CcSEcCtD
Valsartan—Shock—Epirubicin—stomach cancer	0.000122	0.00076	CcSEcCtD
Valsartan—Diarrhoea—Capecitabine—stomach cancer	0.000122	0.000758	CcSEcCtD
Valsartan—Nervous system disorder—Epirubicin—stomach cancer	0.000122	0.000757	CcSEcCtD
Valsartan—Dizziness—Docetaxel—stomach cancer	0.000122	0.000757	CcSEcCtD
Valsartan—Thrombocytopenia—Epirubicin—stomach cancer	0.000122	0.000756	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000121	0.000752	CcSEcCtD
Valsartan—Skin disorder—Epirubicin—stomach cancer	0.000121	0.00075	CcSEcCtD
Valsartan—Insomnia—Methotrexate—stomach cancer	0.00012	0.000746	CcSEcCtD
Valsartan—Myalgia—Doxorubicin—stomach cancer	0.00012	0.000745	CcSEcCtD
Valsartan—Chest pain—Doxorubicin—stomach cancer	0.00012	0.000745	CcSEcCtD
Valsartan—Arthralgia—Doxorubicin—stomach cancer	0.00012	0.000745	CcSEcCtD
Valsartan—Anxiety—Doxorubicin—stomach cancer	0.00012	0.000743	CcSEcCtD
Valsartan—Paraesthesia—Methotrexate—stomach cancer	0.000119	0.000741	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000119	0.00074	CcSEcCtD
Valsartan—Anorexia—Epirubicin—stomach cancer	0.000119	0.000736	CcSEcCtD
Valsartan—Dyspnoea—Methotrexate—stomach cancer	0.000118	0.000735	CcSEcCtD
Valsartan—Somnolence—Methotrexate—stomach cancer	0.000118	0.000733	CcSEcCtD
Valsartan—Dizziness—Capecitabine—stomach cancer	0.000118	0.000733	CcSEcCtD
Valsartan—Dry mouth—Doxorubicin—stomach cancer	0.000117	0.000729	CcSEcCtD
Valsartan—Vomiting—Docetaxel—stomach cancer	0.000117	0.000728	CcSEcCtD
Valsartan—Dyspepsia—Methotrexate—stomach cancer	0.000117	0.000726	CcSEcCtD
Valsartan—Rash—Docetaxel—stomach cancer	0.000116	0.000722	CcSEcCtD
Valsartan—Hypotension—Epirubicin—stomach cancer	0.000116	0.000721	CcSEcCtD
Valsartan—Dermatitis—Docetaxel—stomach cancer	0.000116	0.000721	CcSEcCtD
Valsartan—Decreased appetite—Methotrexate—stomach cancer	0.000116	0.000717	CcSEcCtD
Valsartan—Headache—Docetaxel—stomach cancer	0.000116	0.000717	CcSEcCtD
Valsartan—Anaphylactic shock—Doxorubicin—stomach cancer	0.000115	0.000714	CcSEcCtD
Valsartan—Oedema—Doxorubicin—stomach cancer	0.000115	0.000714	CcSEcCtD
Valsartan—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000115	0.000712	CcSEcCtD
Valsartan—Fatigue—Methotrexate—stomach cancer	0.000115	0.000711	CcSEcCtD
Valsartan—Infection—Doxorubicin—stomach cancer	0.000114	0.00071	CcSEcCtD
Valsartan—Vomiting—Capecitabine—stomach cancer	0.000114	0.000705	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000113	0.000703	CcSEcCtD
Valsartan—Shock—Doxorubicin—stomach cancer	0.000113	0.000703	CcSEcCtD
Valsartan—Nervous system disorder—Doxorubicin—stomach cancer	0.000113	0.000701	CcSEcCtD
Valsartan—Thrombocytopenia—Doxorubicin—stomach cancer	0.000113	0.000699	CcSEcCtD
Valsartan—Rash—Capecitabine—stomach cancer	0.000113	0.000699	CcSEcCtD
Valsartan—Insomnia—Epirubicin—stomach cancer	0.000112	0.000698	CcSEcCtD
Valsartan—Dermatitis—Capecitabine—stomach cancer	0.000112	0.000698	CcSEcCtD
Valsartan—Headache—Capecitabine—stomach cancer	0.000112	0.000694	CcSEcCtD
Valsartan—Skin disorder—Doxorubicin—stomach cancer	0.000112	0.000694	CcSEcCtD
Valsartan—Paraesthesia—Epirubicin—stomach cancer	0.000112	0.000693	CcSEcCtD
Valsartan—Dyspnoea—Epirubicin—stomach cancer	0.000111	0.000688	CcSEcCtD
Valsartan—Somnolence—Epirubicin—stomach cancer	0.000111	0.000686	CcSEcCtD
Valsartan—Anorexia—Doxorubicin—stomach cancer	0.00011	0.000681	CcSEcCtD
Valsartan—Nausea—Docetaxel—stomach cancer	0.00011	0.00068	CcSEcCtD
Valsartan—Dyspepsia—Epirubicin—stomach cancer	0.000109	0.00068	CcSEcCtD
Valsartan—Gastrointestinal pain—Methotrexate—stomach cancer	0.000109	0.000675	CcSEcCtD
Valsartan—Decreased appetite—Epirubicin—stomach cancer	0.000108	0.000671	CcSEcCtD
Valsartan—Hypotension—Doxorubicin—stomach cancer	0.000108	0.000668	CcSEcCtD
Valsartan—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000107	0.000667	CcSEcCtD
Valsartan—Fatigue—Epirubicin—stomach cancer	0.000107	0.000666	CcSEcCtD
Valsartan—Constipation—Epirubicin—stomach cancer	0.000106	0.00066	CcSEcCtD
Valsartan—Nausea—Capecitabine—stomach cancer	0.000106	0.000658	CcSEcCtD
Valsartan—Urticaria—Methotrexate—stomach cancer	0.000106	0.000655	CcSEcCtD
Valsartan—Abdominal pain—Methotrexate—stomach cancer	0.000105	0.000652	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000105	0.000651	CcSEcCtD
Valsartan—Insomnia—Doxorubicin—stomach cancer	0.000104	0.000646	CcSEcCtD
Valsartan—Paraesthesia—Doxorubicin—stomach cancer	0.000103	0.000641	CcSEcCtD
Valsartan—Dyspnoea—Doxorubicin—stomach cancer	0.000103	0.000637	CcSEcCtD
Valsartan—Somnolence—Doxorubicin—stomach cancer	0.000102	0.000635	CcSEcCtD
Valsartan—Gastrointestinal pain—Epirubicin—stomach cancer	0.000102	0.000631	CcSEcCtD
Valsartan—Dyspepsia—Doxorubicin—stomach cancer	0.000101	0.000629	CcSEcCtD
Valsartan—Decreased appetite—Doxorubicin—stomach cancer	0.0001	0.000621	CcSEcCtD
Valsartan—Gastrointestinal disorder—Doxorubicin—stomach cancer	9.94e-05	0.000617	CcSEcCtD
Valsartan—Fatigue—Doxorubicin—stomach cancer	9.92e-05	0.000616	CcSEcCtD
Valsartan—Urticaria—Epirubicin—stomach cancer	9.88e-05	0.000613	CcSEcCtD
Valsartan—Constipation—Doxorubicin—stomach cancer	9.84e-05	0.000611	CcSEcCtD
Valsartan—Abdominal pain—Epirubicin—stomach cancer	9.83e-05	0.00061	CcSEcCtD
Valsartan—Hypersensitivity—Methotrexate—stomach cancer	9.79e-05	0.000608	CcSEcCtD
Valsartan—Asthenia—Methotrexate—stomach cancer	9.54e-05	0.000592	CcSEcCtD
Valsartan—Gastrointestinal pain—Doxorubicin—stomach cancer	9.41e-05	0.000584	CcSEcCtD
Valsartan—Pruritus—Methotrexate—stomach cancer	9.4e-05	0.000584	CcSEcCtD
Valsartan—Hypersensitivity—Epirubicin—stomach cancer	9.16e-05	0.000569	CcSEcCtD
Valsartan—Urticaria—Doxorubicin—stomach cancer	9.14e-05	0.000567	CcSEcCtD
Valsartan—Abdominal pain—Doxorubicin—stomach cancer	9.1e-05	0.000565	CcSEcCtD
Valsartan—Diarrhoea—Methotrexate—stomach cancer	9.09e-05	0.000564	CcSEcCtD
Valsartan—Asthenia—Epirubicin—stomach cancer	8.92e-05	0.000554	CcSEcCtD
Valsartan—Pruritus—Epirubicin—stomach cancer	8.8e-05	0.000546	CcSEcCtD
Valsartan—Dizziness—Methotrexate—stomach cancer	8.79e-05	0.000546	CcSEcCtD
Valsartan—Diarrhoea—Epirubicin—stomach cancer	8.51e-05	0.000528	CcSEcCtD
Valsartan—Hypersensitivity—Doxorubicin—stomach cancer	8.48e-05	0.000526	CcSEcCtD
Valsartan—Vomiting—Methotrexate—stomach cancer	8.45e-05	0.000525	CcSEcCtD
Valsartan—Rash—Methotrexate—stomach cancer	8.38e-05	0.00052	CcSEcCtD
Valsartan—Dermatitis—Methotrexate—stomach cancer	8.37e-05	0.00052	CcSEcCtD
Valsartan—Headache—Methotrexate—stomach cancer	8.33e-05	0.000517	CcSEcCtD
Valsartan—Asthenia—Doxorubicin—stomach cancer	8.26e-05	0.000513	CcSEcCtD
Valsartan—Dizziness—Epirubicin—stomach cancer	8.22e-05	0.000511	CcSEcCtD
Valsartan—Pruritus—Doxorubicin—stomach cancer	8.14e-05	0.000505	CcSEcCtD
Valsartan—Vomiting—Epirubicin—stomach cancer	7.91e-05	0.000491	CcSEcCtD
Valsartan—Nausea—Methotrexate—stomach cancer	7.89e-05	0.00049	CcSEcCtD
Valsartan—Diarrhoea—Doxorubicin—stomach cancer	7.87e-05	0.000489	CcSEcCtD
Valsartan—Rash—Epirubicin—stomach cancer	7.84e-05	0.000487	CcSEcCtD
Valsartan—Dermatitis—Epirubicin—stomach cancer	7.83e-05	0.000486	CcSEcCtD
Valsartan—Headache—Epirubicin—stomach cancer	7.79e-05	0.000484	CcSEcCtD
Valsartan—Dizziness—Doxorubicin—stomach cancer	7.61e-05	0.000472	CcSEcCtD
Valsartan—Nausea—Epirubicin—stomach cancer	7.39e-05	0.000459	CcSEcCtD
Valsartan—Vomiting—Doxorubicin—stomach cancer	7.32e-05	0.000454	CcSEcCtD
Valsartan—Rash—Doxorubicin—stomach cancer	7.26e-05	0.00045	CcSEcCtD
Valsartan—Dermatitis—Doxorubicin—stomach cancer	7.25e-05	0.00045	CcSEcCtD
Valsartan—Headache—Doxorubicin—stomach cancer	7.21e-05	0.000448	CcSEcCtD
Valsartan—Nausea—Doxorubicin—stomach cancer	6.84e-05	0.000424	CcSEcCtD
Valsartan—SLCO1B1—Metabolism—TYMP—stomach cancer	3.21e-05	0.000656	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—FADS1—stomach cancer	3.21e-05	0.000656	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—APOA1—stomach cancer	3.19e-05	0.000652	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HSPB1—stomach cancer	3.17e-05	0.000649	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—AGTR2—stomach cancer	3.17e-05	0.000649	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL6—stomach cancer	3.17e-05	0.000647	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	3.16e-05	0.000645	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ENO1—stomach cancer	3.14e-05	0.000642	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—BMP2—stomach cancer	3.14e-05	0.000641	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—F2R—stomach cancer	3.14e-05	0.000641	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—RORA—stomach cancer	3.12e-05	0.000637	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—TNF—stomach cancer	3.12e-05	0.000637	CbGpPWpGaD
Valsartan—ALB—Hemostasis—SPARC—stomach cancer	3.1e-05	0.000634	CbGpPWpGaD
Valsartan—ALB—Hemostasis—F2R—stomach cancer	3.1e-05	0.000634	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.09e-05	0.000631	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—AKR1C3—stomach cancer	3.09e-05	0.000631	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR1A—stomach cancer	3.05e-05	0.000624	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—PRKCB—stomach cancer	3.04e-05	0.000622	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IRF1—stomach cancer	3.03e-05	0.00062	CbGpPWpGaD
Valsartan—ALB—Metabolism—PGLS—stomach cancer	3.03e-05	0.000619	CbGpPWpGaD
Valsartan—ALB—Metabolism—BLVRB—stomach cancer	3.03e-05	0.000619	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—SREBF2—stomach cancer	3.01e-05	0.000614	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SUCLG1—stomach cancer	2.99e-05	0.000611	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—IDH3B—stomach cancer	2.99e-05	0.000611	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—RORA—stomach cancer	2.97e-05	0.000607	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—PRKCB—stomach cancer	2.96e-05	0.000604	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ANXA1—stomach cancer	2.95e-05	0.000603	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—ALB—stomach cancer	2.94e-05	0.0006	CbGpPWpGaD
Valsartan—ALB—Metabolism—PPAP2A—stomach cancer	2.89e-05	0.00059	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ADRB1—stomach cancer	2.86e-05	0.000584	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CD44—stomach cancer	2.78e-05	0.000569	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ALDOB—stomach cancer	2.78e-05	0.000569	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NDUFV1—stomach cancer	2.78e-05	0.000568	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NDUFS1—stomach cancer	2.78e-05	0.000568	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	2.78e-05	0.000567	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—RPS6—stomach cancer	2.73e-05	0.000558	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	2.72e-05	0.000555	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.7e-05	0.000552	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—PRKCB—stomach cancer	2.69e-05	0.000549	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL6ST—stomach cancer	2.68e-05	0.000547	CbGpPWpGaD
Valsartan—ALB—Hemostasis—CD44—stomach cancer	2.64e-05	0.000539	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.62e-05	0.000536	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.62e-05	0.000535	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ALOX5—stomach cancer	2.59e-05	0.000529	CbGpPWpGaD
Valsartan—ALB—Metabolism—FBP1—stomach cancer	2.57e-05	0.000526	CbGpPWpGaD
Valsartan—ALB—Metabolism—NDUFA2—stomach cancer	2.57e-05	0.000526	CbGpPWpGaD
Valsartan—ALB—Metabolism—CA1—stomach cancer	2.57e-05	0.000526	CbGpPWpGaD
Valsartan—ALB—Metabolism—CKB—stomach cancer	2.57e-05	0.000526	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—DPYD—stomach cancer	2.55e-05	0.00052	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—SERPINE1—stomach cancer	2.53e-05	0.000517	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IL6—stomach cancer	2.51e-05	0.000514	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HBEGF—stomach cancer	2.51e-05	0.000513	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—APOA1—stomach cancer	2.49e-05	0.000509	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—BLVRB—stomach cancer	2.48e-05	0.000506	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PGLS—stomach cancer	2.48e-05	0.000506	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—RHOA—stomach cancer	2.44e-05	0.000499	CbGpPWpGaD
Valsartan—ALB—Metabolism—PLIN2—stomach cancer	2.42e-05	0.000495	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL6R—stomach cancer	2.39e-05	0.000488	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—RHOA—stomach cancer	2.37e-05	0.000485	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PPP2R1A—stomach cancer	2.37e-05	0.000484	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PPAP2A—stomach cancer	2.36e-05	0.000483	CbGpPWpGaD
Valsartan—ALB—Metabolism—CA2—stomach cancer	2.35e-05	0.000481	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GSTP1—stomach cancer	2.32e-05	0.000475	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ADRB2—stomach cancer	2.32e-05	0.000473	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.31e-05	0.000471	CbGpPWpGaD
Valsartan—ALB—Metabolism—PGAM1—stomach cancer	2.29e-05	0.000469	CbGpPWpGaD
Valsartan—ALB—Metabolism—NT5E—stomach cancer	2.29e-05	0.000469	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—HMOX1—stomach cancer	2.29e-05	0.000468	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	2.27e-05	0.000464	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PPP2R1A—stomach cancer	2.27e-05	0.000464	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GSTT1—stomach cancer	2.25e-05	0.00046	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PPP2R1A—stomach cancer	2.24e-05	0.000458	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CYP2A6—stomach cancer	2.22e-05	0.000455	CbGpPWpGaD
Valsartan—ALB—Metabolism—ALDH7A1—stomach cancer	2.19e-05	0.000447	CbGpPWpGaD
Valsartan—ALB—Metabolism—PLCE1—stomach cancer	2.19e-05	0.000447	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—AKR1C3—stomach cancer	2.16e-05	0.000442	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—TYMS—stomach cancer	2.16e-05	0.000441	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—RHOA—stomach cancer	2.16e-05	0.000441	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GSTM1—stomach cancer	2.13e-05	0.000436	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ENO1—stomach cancer	2.11e-05	0.000431	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NDUFA2—stomach cancer	2.11e-05	0.000431	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CA1—stomach cancer	2.11e-05	0.000431	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CKB—stomach cancer	2.11e-05	0.000431	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—FBP1—stomach cancer	2.11e-05	0.000431	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SMAD4—stomach cancer	2.11e-05	0.00043	CbGpPWpGaD
Valsartan—ALB—Metabolism—UMPS—stomach cancer	2.1e-05	0.000429	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CXCL8—stomach cancer	2.08e-05	0.000426	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.07e-05	0.000424	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ERCC2—stomach cancer	2.01e-05	0.00041	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—FYN—stomach cancer	2e-05	0.000409	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PLIN2—stomach cancer	1.98e-05	0.000405	CbGpPWpGaD
Valsartan—ALB—Hemostasis—FYN—stomach cancer	1.98e-05	0.000404	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ALB—stomach cancer	1.97e-05	0.000403	CbGpPWpGaD
Valsartan—ALB—Metabolism—PDHA1—stomach cancer	1.95e-05	0.000399	CbGpPWpGaD
Valsartan—ALB—Metabolism—ECHS1—stomach cancer	1.95e-05	0.000399	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CA2—stomach cancer	1.93e-05	0.000394	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CXCL8—stomach cancer	1.89e-05	0.000387	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—MTHFR—stomach cancer	1.89e-05	0.000385	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PGAM1—stomach cancer	1.88e-05	0.000384	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NT5E—stomach cancer	1.88e-05	0.000384	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—FGFR2—stomach cancer	1.88e-05	0.000384	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.88e-05	0.000384	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CD44—stomach cancer	1.87e-05	0.000382	CbGpPWpGaD
Valsartan—ALB—Metabolism—FADS1—stomach cancer	1.83e-05	0.000375	CbGpPWpGaD
Valsartan—ALB—Metabolism—TYMP—stomach cancer	1.83e-05	0.000375	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.81e-05	0.000371	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALDH7A1—stomach cancer	1.79e-05	0.000366	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PLCE1—stomach cancer	1.79e-05	0.000366	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	1.74e-05	0.000356	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CAV1—stomach cancer	1.74e-05	0.000355	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—APOA1—stomach cancer	1.74e-05	0.000355	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IRS2—stomach cancer	1.72e-05	0.000351	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—UMPS—stomach cancer	1.72e-05	0.000351	CbGpPWpGaD
Valsartan—ALB—Metabolism—SREBF2—stomach cancer	1.72e-05	0.000351	CbGpPWpGaD
Valsartan—ALB—Metabolism—RORA—stomach cancer	1.7e-05	0.000347	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PLAU—stomach cancer	1.69e-05	0.000345	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CAV1—stomach cancer	1.67e-05	0.000341	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—APOA1—stomach cancer	1.66e-05	0.00034	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.66e-05	0.00034	CbGpPWpGaD
Valsartan—ALB—Hemostasis—CAV1—stomach cancer	1.65e-05	0.000337	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	1.65e-05	0.000336	CbGpPWpGaD
Valsartan—ALB—Hemostasis—APOA1—stomach cancer	1.64e-05	0.000336	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PDHA1—stomach cancer	1.6e-05	0.000326	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ECHS1—stomach cancer	1.6e-05	0.000326	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PPP2R1A—stomach cancer	1.59e-05	0.000325	CbGpPWpGaD
Valsartan—ALB—Metabolism—ALDOB—stomach cancer	1.59e-05	0.000325	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PRKCB—stomach cancer	1.59e-05	0.000324	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL6ST—stomach cancer	1.58e-05	0.000323	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PRKCB—stomach cancer	1.57e-05	0.00032	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	1.57e-05	0.00032	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GSTP1—stomach cancer	1.56e-05	0.000319	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—HMOX1—stomach cancer	1.54e-05	0.000314	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PPARG—stomach cancer	1.53e-05	0.000313	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—APC—stomach cancer	1.52e-05	0.00031	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—TYMP—stomach cancer	1.5e-05	0.000307	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—FADS1—stomach cancer	1.5e-05	0.000307	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.5e-05	0.000306	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.5e-05	0.000306	CbGpPWpGaD
Valsartan—ALB—Metabolism—ALOX5—stomach cancer	1.48e-05	0.000302	CbGpPWpGaD
Valsartan—ALB—Metabolism—DPYD—stomach cancer	1.45e-05	0.000297	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—MAPK3—stomach cancer	1.45e-05	0.000297	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—TYMS—stomach cancer	1.45e-05	0.000296	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GSTM1—stomach cancer	1.43e-05	0.000293	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	1.42e-05	0.000291	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL6R—stomach cancer	1.41e-05	0.000288	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SREBF2—stomach cancer	1.41e-05	0.000287	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—RORA—stomach cancer	1.39e-05	0.000284	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—MAPK1—stomach cancer	1.38e-05	0.000283	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—EGFR—stomach cancer	1.38e-05	0.000283	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ALB—stomach cancer	1.38e-05	0.000281	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	1.36e-05	0.000278	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ERCC2—stomach cancer	1.35e-05	0.000275	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—PIK3CA—stomach cancer	1.32e-05	0.00027	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SERPINE1—stomach cancer	1.32e-05	0.00027	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.32e-05	0.000269	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—NOS3—stomach cancer	1.32e-05	0.000269	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—KRAS—stomach cancer	1.31e-05	0.000267	CbGpPWpGaD
Valsartan—ALB—Hemostasis—SERPINE1—stomach cancer	1.3e-05	0.000267	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALDOB—stomach cancer	1.3e-05	0.000266	CbGpPWpGaD
Valsartan—ALB—Metabolism—GSTT1—stomach cancer	1.29e-05	0.000263	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—RHOA—stomach cancer	1.27e-05	0.00026	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP2A6—stomach cancer	1.27e-05	0.00026	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MTHFR—stomach cancer	1.27e-05	0.000259	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NOS3—stomach cancer	1.26e-05	0.000258	CbGpPWpGaD
Valsartan—ALB—Hemostasis—RHOA—stomach cancer	1.26e-05	0.000257	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS3—stomach cancer	1.25e-05	0.000255	CbGpPWpGaD
Valsartan—ALB—Metabolism—AKR1C3—stomach cancer	1.24e-05	0.000253	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.23e-05	0.000251	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.22e-05	0.00025	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALOX5—stomach cancer	1.21e-05	0.000247	CbGpPWpGaD
Valsartan—ALB—Metabolism—ENO1—stomach cancer	1.21e-05	0.000246	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PTGS2—stomach cancer	1.2e-05	0.000246	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—PIK3CA—stomach cancer	1.2e-05	0.000245	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DPYD—stomach cancer	1.19e-05	0.000243	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ERBB2—stomach cancer	1.18e-05	0.000241	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CAV1—stomach cancer	1.17e-05	0.000239	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—APOA1—stomach cancer	1.17e-05	0.000238	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CXCL8—stomach cancer	1.12e-05	0.000228	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.12e-05	0.000228	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HRAS—stomach cancer	1.11e-05	0.000227	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CDKN1B—stomach cancer	1.09e-05	0.000223	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.08e-05	0.000221	CbGpPWpGaD
Valsartan—ALB—Metabolism—CD44—stomach cancer	1.07e-05	0.000218	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL6—stomach cancer	1.06e-05	0.000217	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GSTT1—stomach cancer	1.05e-05	0.000215	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCND1—stomach cancer	1.04e-05	0.000213	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP2A6—stomach cancer	1.04e-05	0.000213	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—JUN—stomach cancer	1.04e-05	0.000212	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.04e-05	0.000212	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PPARG—stomach cancer	1.03e-05	0.00021	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—AKR1C3—stomach cancer	1.01e-05	0.000207	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MMP9—stomach cancer	1.01e-05	0.000207	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CDKN1A—stomach cancer	1.01e-05	0.000206	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ENO1—stomach cancer	9.86e-06	0.000202	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MAPK8—stomach cancer	9.84e-06	0.000201	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	9.7e-06	0.000198	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ALB—stomach cancer	9.24e-06	0.000189	CbGpPWpGaD
Valsartan—ALB—Metabolism—PPP2R1A—stomach cancer	9.09e-06	0.000186	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—VEGFA—stomach cancer	9.08e-06	0.000186	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—STAT3—stomach cancer	8.99e-06	0.000184	CbGpPWpGaD
Valsartan—ALB—Hemostasis—VEGFA—stomach cancer	8.97e-06	0.000183	CbGpPWpGaD
Valsartan—ALB—Metabolism—GSTP1—stomach cancer	8.91e-06	0.000182	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—NOS3—stomach cancer	8.84e-06	0.000181	CbGpPWpGaD
Valsartan—ALB—Metabolism—HMOX1—stomach cancer	8.79e-06	0.00018	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CD44—stomach cancer	8.75e-06	0.000179	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MAPK3—stomach cancer	8.59e-06	0.000176	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	8.49e-06	0.000173	CbGpPWpGaD
Valsartan—ALB—Hemostasis—MAPK3—stomach cancer	8.49e-06	0.000173	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MYC—stomach cancer	8.36e-06	0.000171	CbGpPWpGaD
Valsartan—ALB—Metabolism—TYMS—stomach cancer	8.29e-06	0.000169	CbGpPWpGaD
Valsartan—ALB—Metabolism—GSTM1—stomach cancer	8.19e-06	0.000167	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MAPK1—stomach cancer	8.17e-06	0.000167	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—EGFR—stomach cancer	8.17e-06	0.000167	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PTGS2—stomach cancer	8.08e-06	0.000165	CbGpPWpGaD
Valsartan—ALB—Hemostasis—MAPK1—stomach cancer	8.08e-06	0.000165	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—KRAS—stomach cancer	7.72e-06	0.000158	CbGpPWpGaD
Valsartan—ALB—Metabolism—ERCC2—stomach cancer	7.7e-06	0.000157	CbGpPWpGaD
Valsartan—ALB—Hemostasis—KRAS—stomach cancer	7.63e-06	0.000156	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PPP2R1A—stomach cancer	7.44e-06	0.000152	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PIK3CA—stomach cancer	7.4e-06	0.000151	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GSTP1—stomach cancer	7.3e-06	0.000149	CbGpPWpGaD
Valsartan—ALB—Metabolism—MTHFR—stomach cancer	7.24e-06	0.000148	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—HMOX1—stomach cancer	7.2e-06	0.000147	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PIK3CA—stomach cancer	7.09e-06	0.000145	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PIK3CA—stomach cancer	7.01e-06	0.000143	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TP53—stomach cancer	6.86e-06	0.00014	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—TYMS—stomach cancer	6.78e-06	0.000139	CbGpPWpGaD
Valsartan—ALB—Hemostasis—TP53—stomach cancer	6.78e-06	0.000139	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GSTM1—stomach cancer	6.71e-06	0.000137	CbGpPWpGaD
Valsartan—ALB—Metabolism—CAV1—stomach cancer	6.68e-06	0.000136	CbGpPWpGaD
Valsartan—ALB—Metabolism—APOA1—stomach cancer	6.66e-06	0.000136	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HRAS—stomach cancer	6.56e-06	0.000134	CbGpPWpGaD
Valsartan—ALB—Hemostasis—HRAS—stomach cancer	6.48e-06	0.000132	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.38e-06	0.00013	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ERCC2—stomach cancer	6.3e-06	0.000129	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL6—stomach cancer	6.28e-06	0.000128	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MTHFR—stomach cancer	5.93e-06	0.000121	CbGpPWpGaD
Valsartan—ALB—Metabolism—PPARG—stomach cancer	5.87e-06	0.00012	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CAV1—stomach cancer	5.47e-06	0.000112	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—APOA1—stomach cancer	5.45e-06	0.000111	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.22e-06	0.000107	CbGpPWpGaD
Valsartan—ALB—Metabolism—NOS3—stomach cancer	5.05e-06	0.000103	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PIK3CA—stomach cancer	4.97e-06	0.000102	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PPARG—stomach cancer	4.81e-06	9.82e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PTGS2—stomach cancer	4.62e-06	9.44e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALB—stomach cancer	4.32e-06	8.83e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NOS3—stomach cancer	4.13e-06	8.45e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PTGS2—stomach cancer	3.78e-06	7.73e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—PIK3CA—stomach cancer	2.84e-06	5.81e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PIK3CA—stomach cancer	2.33e-06	4.75e-05	CbGpPWpGaD
